Yahoo Finance

Selecta Biosciences (NASDAQ:SELB) shareholders are up 22% this past week, but still in the red over the last five years

It's nice to see the Selecta Biosciences, Inc. (NASDAQ:SELB) share price up 22% in a week. But will that repair the damage for the weary investors who have owned this stock as it declined over half a ...
Yahoo Finance

Could The Market Be Wrong About Selecta Biosciences, Inc. (NASDAQ:SELB) Given Its Attractive Financial Prospects?

With its stock down 18% over the past month, it is easy to disregard Selecta Biosciences (NASDAQ:SELB). However, a closer look at its sound financials might cause you to think again. Given that ...
FierceBiotech

Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon

Selecta Biosciences and Sobi have laid down a marker in their attempt to challenge Horizon for the gout market, delivering phase 3 data that suggest their SEL-212 candidate can match the efficacy of ...
Nasdaq

Sobi and Selecta Biosciences announce topline data of SEL-212 from the phase 2 COMPARE study supporting the potential for important clinical improvement in patients with ...

STOCKHOLM and WATERTOWN, Mass., Sept. 30, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) and Selecta Biosciences, Inc. (NASDAQ: SELB), today announced topline data for the ...
Nasdaq

Selecta Biosciences and Sobi Announce Topline Data of SEL-212 from the Phase 2 COMPARE Trial Supporting the Potential for Important Clinical Improvement in Patients with ...

WATERTOWN, Mass. and STOCKHOLM, Sweden, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB) and Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI), today announced topline ...